# | Title | Journal | Year | Citations |
---|
1 | Animal research: Reporting in vivo experiments: The ARRIVE guidelines | British Journal of Pharmacology | 2010 | 3,150 |
2 | Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean? | British Journal of Pharmacology | 2004 | 1,839 |
3 | Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo | British Journal of Pharmacology | 1990 | 1,734 |
4 | Principles of early drug discovery | British Journal of Pharmacology | 2011 | 1,689 |
5 | The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin | British Journal of Pharmacology | 2008 | 1,463 |
6 | Guidelines for reporting experiments involving animals: the ARRIVE guidelines | British Journal of Pharmacology | 2010 | 1,415 |
7 | Stimulus‐secretion coupling: the concept and clues from chromaffin and other cells | British Journal of Pharmacology | 1968 | 1,327 |
8 | Microglial M1/M2 polarization and metabolic states | British Journal of Pharmacology | 2016 | 1,308 |
9 | The orphan receptor GPR55 is a novel cannabinoid receptor | British Journal of Pharmacology | 2007 | 1,287 |
10 | The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate | British Journal of Pharmacology | 1983 | 1,263 |
11 | Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP | British Journal of Pharmacology | 2015 | 1,213 |
12 | Therapeutic antibodies: successes, limitations and hopes for the future | British Journal of Pharmacology | 2009 | 1,123 |
13 | Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers | British Journal of Pharmacology | 2018 | 1,122 |
14 | Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects | British Journal of Pharmacology | 2011 | 1,102 |
15 | Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) | British Journal of Pharmacology | 2011 | 1,082 |
16 | The role of inflammation in CNS injury and disease | British Journal of Pharmacology | 2006 | 1,060 |
17 | The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide | British Journal of Pharmacology | 1987 | 1,024 |
18 | Experimental design and analysis and their reporting: new guidance for publication in BJP | British Journal of Pharmacology | 2015 | 981 |
19 | Endothelial dysfunction in diabetes | British Journal of Pharmacology | 2000 | 966 |
20 | Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide | British Journal of Pharmacology | 2001 | 945 |
21 | SIXTH GADDUM MEMORIAL LECTURE NATIONAL INSTITUTE FOR MEDICAL RESEARCH, MILL HILL, JANUARY 1977 | British Journal of Pharmacology | 1977 | 940 |
22 | The use of animal models in diabetes research | British Journal of Pharmacology | 2012 | 932 |
23 | Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brain | British Journal of Pharmacology | 1970 | 922 |
24 | Guide to Receptors and Channels (GRAC), 5th edition | British Journal of Pharmacology | 2011 | 827 |
25 | A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation | British Journal of Pharmacology | 1989 | 811 |
26 | Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors | British Journal of Pharmacology | 1998 | 808 |
27 | Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics | British Journal of Pharmacology | 2009 | 783 |
28 | Impact of OATP transporters on pharmacokinetics | British Journal of Pharmacology | 2009 | 783 |
29 | Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets | British Journal of Pharmacology | 1987 | 748 |
30 | Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor | British Journal of Pharmacology | 2015 | 739 |
31 | l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro | British Journal of Pharmacology | 1990 | 723 |
32 | Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases | British Journal of Pharmacology | 2017 | 722 |
33 | Endothelium‐dependent hyperpolarization of canine coronary smooth muscle | British Journal of Pharmacology | 1988 | 718 |
34 | Role of Transmitter Uptake Mechanisms in Synaptic Neurotransmission | British Journal of Pharmacology | 1971 | 717 |
35 | Minocycline: far beyond an antibiotic | British Journal of Pharmacology | 2013 | 717 |
36 | The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia | British Journal of Pharmacology | 1992 | 709 |
37 | Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes | British Journal of Pharmacology | 2011 | 700 |
38 | The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) | British Journal of Pharmacology | 2000 | 698 |
39 | CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY? | British Journal of Pharmacology | 1978 | 692 |
40 | Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans | British Journal of Pharmacology | 2008 | 689 |
41 | The discovery of nitric oxide and its role in vascular biology | British Journal of Pharmacology | 2006 | 682 |
42 | The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea‐pig ileum longitudinal muscle strip | British Journal of Pharmacology | 1969 | 674 |
43 | Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol | British Journal of Pharmacology | 2002 | 674 |
44 | How corticosteroids control inflammation: Quintiles Prize Lecture 2005 | British Journal of Pharmacology | 2006 | 650 |
45 | Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria | British Journal of Pharmacology | 2008 | 647 |
46 | Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut | British Journal of Pharmacology | 1970 | 644 |
47 | Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies | British Journal of Pharmacology | 1991 | 630 |
48 | OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies | British Journal of Pharmacology | 2012 | 627 |
49 | Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vessels | British Journal of Pharmacology | 1988 | 626 |
50 | Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies | British Journal of Pharmacology | 1991 | 624 |